Abstract SARS-CoV-2 Omicron BA. 1 and BA. 2 subvariants are genetically divergent. We conducted a matched, test-negative, case-control study to estimate duration of protection of …
Background Waning of vaccine protection against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection or coronavirus disease 2019 (Covid-19) is a concern …
Waning SARS-CoV-2 Immunity in Qatar The protection afforded by the mRNA-1273 vaccine against SARS-CoV-2 infection in Qatar seemed to wane over several months after …
The immunity conferred by SARS-CoV-2 vaccines and infections reduces the transmission of the virus. To answer how the effect of immunity is shared between a reduction of …
With the global expansion of the highly transmissible SARS-CoV-2 Delta (B. 1.617. 2) variant, we conducted a matched test-negative case–control study to assess the real-world …
Financial incentives to encourage healthy and prosocial behaviours often trigger initial behavioural change,,,,,,,,,–, but a large academic literature warns against using them …
M Kang, Y Yi, Y Li, L Sun, A Deng, T Hu… - Annals of internal …, 2022 - acpjournals.org
Background: Real-world evidence on inactivated COVID-19 vaccines against the highly transmissible B. 1.617. 2 (Delta) variant of SARS-CoV-2 is limited, leaving an important gap …
X Wu, Y Lu, B Jiang - Landscape and urban planning, 2023 - Elsevier
Non-pharmaceutical interventions (NPIs) remain some of the most effective measures for coping with the ever-changing coronavirus disease 2019 (COVID-19) pandemic. Pandemic …
The promise of efficacious vaccines against SARS-CoV-2 is fulfilled and vaccination campaigns have started worldwide. However, the fight against the pandemic is far from over …